These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10933653)

  • 1. Salicylate induction of phenotypic resistance to quinolones in Serratia marcescens.
    Berlanga M; Viñas M
    J Antimicrob Chemother; 2000 Aug; 46(2):279-82. PubMed ID: 10933653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoroquinolone resistance of Serratia marcescens: sucrose, salicylate, temperature, and pH induction of phenotypic resistance.
    Begic S; Worobec EA
    Can J Microbiol; 2007 Nov; 53(11):1239-45. PubMed ID: 18026218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of an efflux pump in Serratia marcescens.
    Berlanga M; Vázquez JL; Hernandez-Borrell J; Montero MT; Viñas M
    Microb Drug Resist; 2000; 6(2):111-7. PubMed ID: 10990265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the outer membrane in the accumulation of quinolones by Serratia marcescens.
    Berlanga M; Ruiz N; Hernandez-Borrell J; Montero T; Viñas M
    Can J Microbiol; 2000 Aug; 46(8):716-22. PubMed ID: 10941517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of Serratia marcescens porins in antibiotic resistance.
    Ruiz N; Montero T; Hernandez-Borrell J; Viñas M
    Microb Drug Resist; 2003; 9(3):257-64. PubMed ID: 12959404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the outer membrane for quinolone resistance in enterobacteria.
    Dechène M; Leying H; Cullmann W
    Chemotherapy; 1990; 36(1):13-23. PubMed ID: 2106416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incomplete cross-resistance of nalidixic and pipemidic acid-resistant variants of Serratia marcescens against ciprofloxacin, enoxacin, and norfloxacin.
    Traub WH
    Chemotherapy; 1985; 31(1):34-9. PubMed ID: 3156026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinolone resistance in clinical isolates of Serratia marcescens.
    Fujimaki K; Fujii T; Aoyama H; Sato K; Inoue Y; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1989 May; 33(5):785-7. PubMed ID: 2546493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonspecific resistance of Serratia marcescens against antimicrobial drugs. Resistance or decreased susceptibility of phenotypic variants against chloramphenicol, nalidixic acid, nitrofurantoin, sulfonamides and trimethoprim.
    Traub WH; Fukushima PI
    Chemotherapy; 1979; 25(4):196-203. PubMed ID: 378575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic characterization of quinolone-resistant mutants of Enterobacteriaceae selected from wild type, gyrA type and multiply-resistant (marA) type strains.
    Piddock LJ; Hall MC; Walters RN
    J Antimicrob Chemother; 1991 Aug; 28(2):185-98. PubMed ID: 1663926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of salicylates on antibiotic sensitivity.
    Esposito S; Noviello S; Maggiolo F
    J Chemother; 1990 Apr; 2(2):87-90. PubMed ID: 2163438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification by analgesics of the susceptibility to antibiotics in Serratia marcescens.
    Puig M; Palomar J; Lorén JG; Viñas M
    New Microbiol; 1995 Oct; 18(4):385-90. PubMed ID: 8590391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The synergic effects of quinolones and oral cephem antibiotics on Serratia marcescens.
    Otsuki M; Nishino T
    J Antimicrob Chemother; 1996 Nov; 38(5):771-6. PubMed ID: 8961046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of nalidixic acid and mitomycin C on growth and biosynthesis of extracellular proteins by Serratia marcescens].
    Iusupova DV; Sokolova RB; Petukhova EV
    Antibiot Khimioter; 1993; 38(8-9):16-21. PubMed ID: 8037570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salicylate-inducible antibiotic resistance in Pseudomonas cepacia associated with absence of a pore-forming outer membrane protein.
    Burns JL; Clark DK
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2280-5. PubMed ID: 1280056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of outer membrane in Serratia marcescens intrinsic resistance to antibiotics.
    Sánchez L; Ruiz N; Leranoz S; Viñas M; Puig M
    Microbiologia; 1997 Sep; 13(3):315-20. PubMed ID: 9353750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conditions required for the bactericidal activity of 4-quinolones against Serratia marcescens.
    Lewin CS; Smith JT
    J Med Microbiol; 1990 Jul; 32(3):211-4. PubMed ID: 2165168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of nalidixic acid resistance for detecting salmonellae with decreased ciprofloxacin susceptibility.
    Albayrak F; Cokca F; Erdem B; Aysev AD
    Int J Antimicrob Agents; 2004 Apr; 23(4):332-6. PubMed ID: 15081080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nalidixic acid susceptibility testing of clinical isolates of Serratia marcescens.
    Jollick JD; Schervish-Swierkosz EM; Brown WJ
    Antimicrob Agents Chemother; 1973 Nov; 4(5):532-7. PubMed ID: 4598848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evolution of resistance to quinolones in Salmonella enterica in our setting].
    Ruiz M; Sirvent E; Hernández C; Rodríguez JC; Royo G
    Rev Esp Quimioter; 1999 Dec; 12(4):366-8. PubMed ID: 10855017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.